Suppr超能文献

50 岁以上伴非严重外周骨折患者的椎体骨折评估(VFA)。

Vertebral fracture assessment (VFA) in patients over 50 years of age with a non-severe peripheral fracture.

机构信息

Department of Rheumatology, Amiens University Hospital, Amiens, France.

Department of Pharmacology, Amiens University Hospital, Amiens, France.

出版信息

Osteoporos Int. 2020 Aug;31(8):1477-1486. doi: 10.1007/s00198-020-05400-5. Epub 2020 Apr 7.

Abstract

UNLABELLED

The prevalence of unknown vertebral fractures evaluated by systematic vertebral fracture assessment (VFA) was 21% in patients over 50 years of age who suffered from a recent low-trauma non-severe peripheral fracture. The outcome of VFA resulted in changes in the management of osteoporosis.

INTRODUCTION

The aim of this study was to evaluate the utility of VFA in detecting vertebral fractures (VFs) in patients over 50 years of age, who suffered from a recent low-trauma non-severe peripheral fracture.

METHODS

This was an observational, single-center, cross-sectional study conducted in patients over 50 years of age, who presented a recent low-trauma non-severe peripheral fracture and were identified by the Fracture Liaison Service (FLS) of Amiens University Hospital between December 2017 and March 2019. VFA was interpreted by two trained rheumatologists providing a consensual reading using Genant semi-quantitative assessment.

RESULTS

Of the 359 eligible patients, 114 patients (31.8%) were included (mean age 65.6 ± 8.4 years; 89.5% female). Twenty-four patients (21%) had one or more VF diagnosed by VFA. The total number of VF diagnosed by VFA was 30: 20 VF (66.7%) grade 1, 7 VF (23.3%) grade 2, and 3 VF (10%) grade 3. Among the 24 patients with at least one prevalent VF diagnosed by VFA, 18 patients had an osteoporosis medication adaptation after the VFA results (16 osteoporosis medication initiation and 2 treatment intensification), and 6 patients would have had an osteoporosis medication even without the VFA results (66.7% versus 33.3% respectively, p < 0.001). Of the 51 patients receiving an osteoporosis medication after DXA and VFA, 18 patients (35.3%) had a change in the management of osteoporosis after knowing the outcome of VFA. All the VFs diagnosed by VFA were unknown before. We did not evidence any threshold (age, T-score, height loss) below which no VF was detected.

CONCLUSIONS

Our study demonstrates the usefulness of systematic VFA to detect prevalent VF in patients over 50 years of age who suffer from a recent non-severe peripheral fracture.

摘要

背景

通过系统的椎体骨折评估(VFA)评估,50 岁以上近期发生低创伤非严重外周骨折的患者中,未知椎体骨折的患病率为 21%。VFA 的结果改变了骨质疏松症的管理。

目的

本研究旨在评估 VFA 在检测 50 岁以上近期发生低创伤非严重外周骨折患者的椎体骨折(VF)中的作用。

方法

这是一项在 2017 年 12 月至 2019 年 3 月期间,通过阿美因斯大学医院骨折联络服务(FLS)识别的 50 岁以上近期发生低创伤非严重外周骨折的患者中进行的观察性、单中心、横断面研究。VFA 由两名经过培训的风湿病学家进行解读,使用 Genant 半定量评估提供共识解读。

结果

在 359 名符合条件的患者中,纳入了 114 名患者(31.8%)(平均年龄 65.6±8.4 岁;89.5%为女性)。24 名患者(21%)通过 VFA 诊断出一个或多个 VF。VFA 诊断的 VF 总数为 30 个:20 个 VF(66.7%)为 1 级,7 个 VF(23.3%)为 2 级,3 个 VF(10%)为 3 级。在 24 名至少有一个通过 VFA 诊断的 VF 的患者中,18 名患者在 VFA 结果后调整了骨质疏松症药物(16 名开始使用骨质疏松症药物,2 名药物强化),6 名患者即使没有 VFA 结果也将使用骨质疏松症药物(分别为 66.7%和 33.3%,p<0.001)。在接受 DXA 和 VFA 后接受骨质疏松症药物治疗的 51 名患者中,18 名(35.3%)在了解 VFA 结果后改变了骨质疏松症的治疗方法。所有通过 VFA 诊断的 VF 在之前均未被发现。我们没有发现任何低于某个阈值(年龄、T 评分、身高损失)时不会检测到 VF 的证据。

结论

本研究表明,系统的 VFA 可用于检测 50 岁以上近期发生非严重外周骨折患者的已知 VF。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验